Zelquistinel in the Treatment of Adults With Major Depressive Disorder

NCT03726658 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: AGN-241751
DRUG: Placebo

Sponsor

Syndeio Biosciences, Inc